NeuroSense Therapeutics Ltd. (NRSN) NASDAQ
0.83
+0.07(+9.21%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.83
+0.07(+9.21%)
Currency In USD
| Market Cap | 22.32M |
| Enterprise Value | 19.02M |
| P/E Ratio | -3.24 |
| PEG Ratio | 0.21 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | -40.62 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -3.07 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | June 30, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -3.87 |
| Return On Equity | -12.64 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -9.88M |
| Net Income | -10.21M |
| Diluted EPS | -0.55 |
| Total Cash | 666,000 |
| Total Cash/Share | 0.03 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0.71 |
| Book Value Per Share | -0.02 |
| 52-Week Change | -12.4 |
| 52-Week High | 2.6 |
| 52-Week Low | 0.63 |
| Moving Average 50 Days | 0.87 |
| Moving Average 200 Days | 1.18 |
| Average Volume | 205,506 |
| Shares Outstanding | 24.67M |
| % Held by Institutions | 1.36 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |